|Articles|April 1, 2012

Contemporary OB-GYN, Digital Edition, April 2012

New biomarkers for ovarian Ca : OVA1 & ROMA in diagnosis AIN and anal cancer : Who should be screened? Clinician to Clinician : It takes a big man to admit he's wrong SMFM Consult : Advanced age and antepartum stillbirth

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Latest CME

Video

Community Oncology Connections™: Clarifying Novel Treatment Pathways in HER2+ Breast Cancer – North Carolina

Girish Kunapareddy, MD; Sara M. Tolaney, MD, MPH

Video

Community Oncology Connections™: Clarifying Novel Treatment Pathways in HER2+ Breast Cancer – Wyoming & Montana

Yan Ji, MD; Neil M. Iyengar, MD

Video

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Danielle Nance, MD; Kimberley Youkhana, MD

Contemporary OB-GYN, Digital Edition, April 2012

Latest CME

Community Oncology Connections™: Clarifying Novel Treatment Pathways in HER2+ Breast Cancer – North Carolina

Community Oncology Connections™: Clarifying Novel Treatment Pathways in HER2+ Breast Cancer – Wyoming & Montana

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Trending on Contemporary OB/GYN

Weekly review: Individualized TRT, acetaminophen safety reaffirmed, and more

SMFM in midst of first annual High-Risk Pregnancy Awareness Week

Clinical pearls into ACOG's postmenopausal bleeding guidelines with Susan Loeb-Zeitlin, MD, FACOG

Nearly 18 million US women aged 45 to 64 overdue for cancer screening, study finds

Comorbidities associated with lower HRT uptake may reflect overcautious prescribing